Shareholder Activism

Overview

Our firm has developed the premier practice in the United States in representing corporations against all forms of shareholder activism, including dissidents’ efforts to seek board representation, de-stagger board composition, weaken antitakeover defenses and implement other special interest shareholder proposals.  We have recently represented many Fortune 500 and other companies in responding to shareholder activism, and have represented many of the largest U.S. companies in successfully negotiating non-public resolutions with the largest and best-known activist investors, including Carl Icahn, Starboard Value, Glenview Capital Management, GAMCO Asset Management and Trian Partners.  Our firm also represented the Business Roundtable and the U.S. Chamber of Commerce in their successful challenge of the SEC’s “proxy access” rule, which would have required director candidates nominated by certain large shareholders be included in a company’s proxy materials.

In responding to specific shareholder activism situations, we integrate our firm’s exceptional understanding of securities regulation and corporate governance, M&A and litigation to bring targeted solutions to each of our clients.  Our multidisciplinary approach enables us to explore a full range of options for each activist situation, including potential regulatory and litigation remedies, aggressive proxy contests, or quick and effective engagement with the activist, if appropriate, to resolve a dispute before it becomes a public contest.

We also advise clients on an array of corporate governance-related matters that impact shareholder activism, including composition, procedures and responsibilities of boards and committees, analysis of director independence issues, fiduciary duty issues and D&O indemnification and insurance issues. We draw on our extensive experience in corporate governance matters to provide advice that integrates both current best practices and practical judgments to address complex situations that pose regulatory and liability risks. Our lawyers are active in developing and reviewing governance policies and have developed deep proficiency in preparing and tailoring the key governance documents responsive to the needs of our clients.

Gibson Dunn has recently advised a broad range of corporate clients in activist situations and activism preparedness matters, including Hewlett Packard Enterprise, Trinity Industries, Tenet Healthcare Corp., Marvell Technology, Depomed, Inc. and Towers Watson.

RECENT PUBLICATIONS

Webcast: M&A Insights – How to Use CVRs to Bridge Valuation Gaps, DOJ Self-Disclosure Guidelines for M&A, and Shareholder Activism Update

-December 6, 2023

M&A Report – Annual Activism Update – 2022

-August 21, 2023

Shareholder Proposal Developments During the 2023 Proxy Season

-July 25, 2023

M&A Report – Annual Activism Update – 2021

-August 9, 2022

Shareholder Proposal Developments During the 2022 Proxy Season

-July 11, 2022

Webcast: 2022 SEC Disclosure & Proxy Season Outlook

-January 12, 2022

Shareholder Proposal Developments During the 2021 Proxy Season

-August 19, 2021

M&A Report – 2020 Year-End Activism Update

-February 22, 2021

M&A Report – 2020 Mid-Year Activism Update

-October 9, 2020

Shareholder Proposal Developments During the 2020 Proxy Season

-August 4, 2020

M&A Report – 2019 Year-End Activism Update

-May 11, 2020

Reconsidering Poison Pills

-March 26, 2020

M&A Report – 2019 Mid-Year Activism Update

-October 7, 2019

SEC Issues New Guidance for Proxy Advisors and Investment Advisers Engaged in the Proxy Voting Process

-August 23, 2019

M&A Report – 2018 Year-End Activism Update

-March 25, 2019

M&A Report – 2018 Mid-Year Activism Update

-October 3, 2018

Shareholder Proposal Developments During the 2018 Proxy Season

-July 12, 2018

M&A Report – 2017 Year-End Activism Update

-January 29, 2018

M&A Report: 2017 Mid-Year Activism Update

-August 15, 2017

Shareholder Proposal Developments During the 2017 Proxy Season

-June 29, 2017

M&A Report – 2016 Year-End Activism Update

-January 9, 2017

Planning for Your Annual Shareholder Meeting: Selected Considerations for a Virtual-Only Meeting

-November 16, 2016

M&A Report – 2016 Mid-Year Activism Update

-August 16, 2016

Shareholder Proposal Developments During the 2016 Proxy Season

-June 28, 2016

The Heat is on: Update on Shareholder Activism in Germany

-September 3, 2015

Shareholder Proposal Developments During the 2015 Proxy Season

-July 15, 2015

Shareholder Activism – The European Dimension “En Garde”

-March 30, 2015

Advance Notice Bylaws: Trends and Challenges

-January 22, 2015

Webcast – Shareholder Activism

-September 18, 2014

Shareholder Proposal Developments During the 2014 Proxy Season

-June 25, 2014

Webcast – Shareholder Activism – The New Dialogue

-April 8, 2014

Shareholder Activism in the UK:  An Introduction to the “Tools in the Box” for 2014

-February 18, 2014

A Look At Shareholder Activism In The Retail Sector

-February 10, 2014

UK/EU Corporate Governance Update: New Tools and Guidance for the Active Investor

-January 28, 2014

Considerations for Public Company Directors in the 2014 Proxy Season and Beyond

-January 16, 2014

UK Corporate Governance Developments: 2013 Mid-Year Update

-August 27, 2013

Shareholder Proposal Developments During the 2013 Proxy Season

-July 9, 2013

Shareholder Activism in the U.K. – an Introduction

-May 31, 2013

Shareholder Activism in the UK: An Introduction

-March 15, 2013

M&A Report – Winter 2013

-February 19, 2013

Delaware Court of Chancery Rules “Don’t Ask, Don’t Waive” Standstill Provision Unenforceable

-December 3, 2012

Delaware Court of Chancery Expedites Proceedings to Enjoin Enforcement of Advance Notice Bylaw

-May 17, 2012